- Home
- OZK vs RYTM Comparison
OZK vs RYTM Comparison
Compare OZK & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OZK
- RYTM
- Stock Information
- Founded
- OZK 1903
- RYTM 2008
- Country
- OZK United States
- RYTM United States
- Employees
- OZK N/A
- RYTM N/A
- Industry
- OZK Major Banks
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- OZK Finance
- RYTM Health Care
- Exchange
- OZK Nasdaq
- RYTM Nasdaq
- Market Cap
- OZK 4.4B
- RYTM 3.8B
- IPO Year
- OZK 1997
- RYTM 2017
- Fundamental
- Price
- OZK $43.76
- RYTM $62.15
- Analyst Decision
- OZK Hold
- RYTM Strong Buy
- Analyst Count
- OZK 9
- RYTM 12
- Target Price
- OZK $49.13
- RYTM $76.75
- AVG Volume (30 Days)
- OZK 788.1K
- RYTM 632.6K
- Earning Date
- OZK 07-16-2025
- RYTM 05-07-2025
- Dividend Yield
- OZK 3.75%
- RYTM N/A
- EPS Growth
- OZK 2.15
- RYTM N/A
- EPS
- OZK 6.10
- RYTM N/A
- Revenue
- OZK $1,488,963,000.00
- RYTM $136,863,000.00
- Revenue This Year
- OZK $15.44
- RYTM $37.88
- Revenue Next Year
- OZK $5.32
- RYTM $72.84
- P/E Ratio
- OZK $7.27
- RYTM N/A
- Revenue Growth
- OZK 6.47
- RYTM 48.88
- 52 Week Low
- OZK $35.71
- RYTM $35.35
- 52 Week High
- OZK $53.64
- RYTM $68.58
- Technical
- Relative Strength Index (RSI)
- OZK 44.41
- RYTM 53.15
- Support Level
- OZK $43.72
- RYTM $58.72
- Resistance Level
- OZK $45.59
- RYTM $63.24
- Average True Range (ATR)
- OZK 0.85
- RYTM 2.40
- MACD
- OZK -0.33
- RYTM -0.09
- Stochastic Oscillator
- OZK 1.85
- RYTM 71.71
About OZK Bank OZK
Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides a range of banking services which include deposit services such as checking, savings, money market, time deposit, and individual retirement accounts to loan services like real estate, consumer, commercial, and industrial loans. Apart from providing traditional banking products and services it also provides treasury management, trust and wealth management, financial planning, online banking, and other related services.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.